Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011

Mode of death in heart failure: findings from the ATLAS trial.

Heart (British Cardiac Society)·2002

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.

Journal of cardiac failure·2001

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Archives of internal medicine·2001

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.

European journal of heart failure·2000

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

European heart journal·2000

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.

Circulation·2026

Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India.

Circulation·2026

Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.

Circulation·2026

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Circulation·2026

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Circulation·2026

Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.

Circulation·2026

Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries.

European journal of internal medicine·2026

Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England.

European heart journal·2026

Cardiovascular-Kidney-Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data - Large-Scale Epidemiological Study.

Circulation journal : official journal of the Japanese Circulation Society·2026

Management and Outcomes of Acute Coronary Syndrome during and after the COVID-19 Pandemic in Kurume City: A Multicenter Observational Study.

The Kurume medical journal·2026

Vascular medicine in older adults - A call for structured cooperation to improve care.

VASA. Zeitschrift fur Gefasskrankheiten·2026

Age-specific coronary outcomes in subacute Kawasaki disease.

American heart journal·2026

Related Experiment Videos

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

Related Concept Videos

Effect of nesiritide in patients with acute decompensated heart failure.

Mode of death in heart failure: findings from the ATLAS trial.

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.

Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India.

Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.

Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries.

Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England.

Cardiovascular-Kidney-Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data - Large-Scale Epidemiological Study.

Management and Outcomes of Acute Coronary Syndrome during and after the COVID-19 Pandemic in Kurume City: A Multicenter Observational Study.

Vascular medicine in older adults - A call for structured cooperation to improve care.

Age-specific coronary outcomes in subacute Kawasaki disease.

Related Experiment Videos

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

Related Concept Videos

Related Articles